NCBI Gene Info:Predicted to enable chromatin binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II and positive regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. Is expressed in several structures, including extended germ band embryo; larval ventral nerve cord; and presumptive embryonic/larval central nervous system. Used to study macular degeneration. Orthologous to human PRDM13 (PR/SET domain 13). [provided by Alliance of Genome Resources, Apr 2022] |